| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a5df36a8e925d82e86a4d9bbc239b1f9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d32a49211015b18ecef5a3a5195bf06e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2081 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-54 |
| filingDate |
1999-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80d98042355043b1a7e9675246496eb5 |
| publicationDate |
1999-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9958107-A2 |
| titleOfInvention |
Oral or mucosal preparation containing an active ingredient, with controlled active ingredient release, and its use |
| abstract |
The invention relates to the use, notably in human and veterinary medicine, of a preparation containing a first group of particles and at least one other group of particles which is not identical to the first group of particles, for achieving a controlled release of an active ingredient contained in the cores of the particles. The preparation is administered orally, rectally, vaginally, etc. The active ingredient is released in the corresponding medium and absorbed transmucosally. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9889152-B2 |
| priorityDate |
1998-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |